The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy

Wang, Qi; Qiao, Wenying; Liu, Biyu; Li, Jianjun; Yuan, Chunwang; Long, Jiang; Hu, Caixia; Zang, Chaoran; Zheng, Jiasheng; Zhang, Yonghong

doi:10.1186/s12876-022-02180-6

BMC Gastroenterology

Article metrics
Last updated: Fri, 19 Apr 2024 7:48:31 Z

The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy

Access & Citations

1642

Article Accesses
6

Web of Science
8

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-230X

Contact us

Submission enquiries: bmcgastroenterology@biomedcentral.com
General enquiries: ORSupport@springernature.com